SARINA ELMARIAH: Open Payments
NPI 1962608653 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$221,582 in 78 payments from 5 companies in 2025. Trend: 2023 $104,718 · 2024 $146,032 · 2025 $221,582
Consulting: $190,980Speaker / faculty: $19,982Travel & lodging: $7,921Food & beverage: $1,680Grant: $1,000Education: $19
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 27 | $103,017 |
| Galderma Laboratories, L.P. | 14 | $67,286 |
| Novartis Pharmaceuticals Corporation | 26 | $34,107 |
| Regeneron Healthcare Solutions, Inc. | 8 | $12,901 |
| Regeneron Pharmaceuticals, Inc. | 3 | $4,270 |
Products named: DUPIXENT, NEMLUVIO.
Industry payments across CA — which companies pay providers there.
